Ras-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy

Li,Yang‑Jun; Zhang,Jie; Han,Jing; Du,Zhao‑Jiang; Wang,Ping; Guo,Yong

doi:10.3892/etm.2014.2081

Ras-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy

Authors:
- Yang‑Jun Li
- Jie Zhang
- Jing Han
- Zhao‑Jiang Du
- Ping Wang
- Yong Guo
View Affiliations

Affiliations: Department of Ophthalmology, Tangdu Hospital, The Fourth Military Medical University of the PLA, Xian, Shaanxi 710038, P.R. China
Published online on: November 19, 2014 https://doi.org/10.3892/etm.2014.2081
Pages: 89-97

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study used a streptozotocin (STZ)‑induced rat model of diabetes to investigate whether Ras‑related C3 botulinum toxin substrate 1 (Rac1) was involved in the pathogenesis of diabetic retinopathy. The effects of Rac1 inhibition on vascular endothelial (VE)‑cadherin and β‑catenin expression in high glucose‑induced rat retinal endothelial cells (RRECs) were additionally examined. Rac1 activation in the retinas from STZ‑induced diabetic rats and in high glucose‑induced RRECs was measured by reverse transcription‑quantitative polymerase chain reaction analysis, immunohistochemistry and western blot analysis. The expression levels of VE‑cadherin and β‑catenin were also examined with or without Rac1 inhibition through small interfering (si)RNA transfection. STZ‑induced diabetes was associated with an increase in the vascular permeability of the retina. Furthermore, Rac1 activation was increased in the retina of STZ‑induced diabetic rats and in high glucose‑induced RRECs compared with that in the controls. Immunohistochemistry showed that immunostaining of Rac1 was localized in the outer plexiform, inner nuclear, inner plexiform and ganglion cell layers and in the retinal microvasculature of rats. The expression of β‑catenin was increased in the retinas of the diabetic rats at four, eight and 12 weeks after the induction of diabetes compared with that in the controls. Additionally, Rac1 activation was required for the high glucose‑induced VE‑cadherin expression decrease and for β‑catenin expression in high glucose‑induced RRECs. Rac1 inhibition by Rac1‑siRNA transfection effectively prevented hyperpermeability, β‑catenin expression and the VE‑cadherin expression decrease in high glucose‑induced RRECs. In conclusion, diabetes affects the expression of Rac1 in the retina. Rac1 may be involved in the diabetes‑induced damage and/or alterations to the blood‑retinal barrier through changes in VE‑cadherin and β‑catenin expression.

View Figures

View References

1	Nelson WJ: Adaptation of core mechanisms to generate cell polarity. Nature. 422:766–774. 2003. View Article : Google Scholar : PubMed/NCBI
2	Corada M, Mariotti M, Thurston G, et al: Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci USA. 96:9815–9820. 1999. View Article : Google Scholar : PubMed/NCBI
3	May C, Doody JF, Abdullah R, et al: Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature. Blood. 105:4337–4344. 2005. View Article : Google Scholar : PubMed/NCBI
4	Weis WI and Nelson WJ: Re-solving the cadherin-catenin-actin conundrum. J Biol Chem. 281:35593–35597. 2006. View Article : Google Scholar : PubMed/NCBI
5	Potter MD, Barbero S and Cheresh DA: Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem. 280:31906–31912. 2005. View Article : Google Scholar : PubMed/NCBI
6	Gumbiner BM: Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol. 6:622–634. 2005. View Article : Google Scholar : PubMed/NCBI
7	Hall A: Rho GTPases and the control of cell behaviour. Biochem Soc Trans. 33:891–895. 2005. View Article : Google Scholar : PubMed/NCBI
8	Ehrlich JS, Hansen MD and Nelson WJ: Spatio-temporal regulation of Rac1 localization and lamellipodia dynamics during epithelial cell-cell adhesion. Dev Cell. 3:259–270. 2002. View Article : Google Scholar : PubMed/NCBI
9	van Wetering S, van Buul JD, Quik S, et al: Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci. 115:1837–1846. 2002.PubMed/NCBI
10	Hage B, Meinel K, Baum I, Giehl K and Menke A: Rac1 activation inhibits E-cadherin-mediated adherens junctions via binding to IQGAP1 in pancreatic carcinoma cells. Cell Commun Signal. 7:232009. View Article : Google Scholar : PubMed/NCBI
11	Monaghan-Benson E and Burridge K: The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J Biol Chem. 284:25602–25611. 2009. View Article : Google Scholar : PubMed/NCBI
12	Wu X, Tu X, Joeng KS, et al: Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell. 133:340–353. 2008. View Article : Google Scholar : PubMed/NCBI
13	Xu Q, Qaum T and Adamis AP: Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci. 42:789–794. 2001.PubMed/NCBI
14	Gao G, Shao C, Zhang SX, et al: Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage. Diabetologia. 46:689–698. 2003.PubMed/NCBI
15	Boeri D, Cagliero E, Podestá F and Lorenzi M: Vascular wall von Willebrand factor in human diabetic retinopathy. Invest Ophthalmol Vis Sci. 35:600–607. 1994.PubMed/NCBI
16	Lecomte M, Paget C, Ruggiero D, Wiernsperger N and Lagarde M: Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid in bovine retinal microvessels. J Neurochem. 66:2160–2167. 1996. View Article : Google Scholar : PubMed/NCBI
17	Elbashir SM, Harborth J, Lendeckel W, et al: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:494–498. 2001. View Article : Google Scholar : PubMed/NCBI
18	Kim JH, Kim JH, Jun HO, Yu YS and Kim KW: Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy. Am J Pathol. 176:1517–1524. 2010. View Article : Google Scholar : PubMed/NCBI
19	Sander EE, van Delft S, ten Klooster JP, et al: Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J Cell Biol. 143:1385–1398. 1998. View Article : Google Scholar : PubMed/NCBI
20	Do carmo A, Ramos P, Reis A, Proença R and Cunha-vaz JG: Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes. Exp Eye Res. 67:569–575. 1998. View Article : Google Scholar
21	Moldovan L, Moldovan NI, Sohn RH, Parikh SA and Goldschmidt-Clermont PJ: Redox changes of cultured endothelial cells and actin dynamics. Circ Res. 86:549–557. 2000. View Article : Google Scholar : PubMed/NCBI
22	Peterson LJ, Wittchen ES, Geisen P, Burridge K and Hartnett ME: Heterotypic RPE-choroidal endothelial cell contact increases choroidal endothelial cell transmigration via PI 3-kinase and Rac1. Exp Eye Res. 84:737–744. 2007. View Article : Google Scholar : PubMed/NCBI
23	Wójciak-Stothard B, Potempa S, Eichholtz T and Ridley AJ: Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci. 114:1343–1355. 2001.PubMed/NCBI
24	Braga VM, Del Maschio A, Machesky L and Dejana E: Regulation of cadherin function by Rho and Rac: modulation by junction maturation and cellular context. Mol Biol Cell. 10:9–22. 1999. View Article : Google Scholar : PubMed/NCBI
25	Gavard J and Gutkind JS: VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol. 8:1223–1234. 2006. View Article : Google Scholar : PubMed/NCBI
26	Stockton RA, Schaefer E and Schwartz MA: p21-activated kinase regulates endothelial permeability through modulation of contractility. J Biol Chem. 279:46621–46630. 2004. View Article : Google Scholar : PubMed/NCBI
27	Zhang XZ, Huang X, Qiao JH, Zhang JJ and Zhang MX: Inhibition of hypoxia-induced retinal neovascularization in mice with short hairpin RNA targeting Rac1, possibly via blockading redox signaling. Exp Eye Res. 92:473–481. 2011. View Article : Google Scholar : PubMed/NCBI
28	Navaratna D, McGuire PG, Menicucci G and Das A: Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes. 56:2380–2387. 2007. View Article : Google Scholar : PubMed/NCBI
29	Chen Y, Hu Y, Zhou T, et al: Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. Am J Pathol. 175:2676–2685. 2009. View Article : Google Scholar : PubMed/NCBI